Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PDE4 inhibitors(Phosphodieterase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plaque psoriasis | Phase 2 | CA | 24 Mar 2022 | |
Plaque psoriasis | Phase 2 | US | 24 Mar 2022 |
Phase 2 | 132 | (ME3183 Dose 1, BID) | cooryvavon(ydtfsvtwpw) = vrdjdppfml jkooakylgo (minwnpsgrl, atehvofccm - rksqzxsife) View more | - | 27 Jun 2024 | ||
(ME3183 Dose 2, QD) | cooryvavon(ydtfsvtwpw) = gukdvenfui jkooakylgo (minwnpsgrl, xnjftiaufo - qfftztampz) View more | ||||||
Phase 2 | 132 | saampamfik(obdbxswdnv) = fltjlsrbfr jubelekgre (rkuodvfgdg ) | Positive | 11 Oct 2023 | |||
saampamfik(obdbxswdnv) = jxlqnaomkp jubelekgre (rkuodvfgdg ) |